Drug
Hzn 457
Hzn 457: highest development phase Phase 1, developed by Horizon Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Horizon Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| HZN-457 NCT05565768 | Phase 1 | Healthy |
Latest
No recent events.
Follow Hzn 457 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.